%0 Journal Article
%T Nivestim  (filgrastim): a new, convenient, daily G-CSF is effective for the prevention of febrile neutropenia
%A EJHP Author
%J European Journal of Oncology Pharmacy
%D 2010
%I Pharma Publishing & Media Europe
%X Clinical research has shown that Nivestim can reduce the duration of chemotherapy-induced neutropenia (CIN) and prevent febrile neutropenia (FN) in patients with cancer.
%U http://www.ppme.eu/Publications/EJOP/Journal-information/Previous-issues/EJOP-Vol.4-2010-Issue-2/Industry-Science/Nivestim-filgrastim-a-new-convenient-daily-G-CSF-is-effective-for-the-prevention-of-febrile-neutropenia